Peptide record

TPDB08994

Antibacterial Anticancer Antifungal Antiviral Hemolysis Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08994
Antibacterial Anticancer Antifungal Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb dbAMP 3.0 APD_complete APD_hemolytic Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 18-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLFSLIPHAIGGLISAFK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C96H147N21O21
RNDCEQMTWYV
ILF
1931.35
10.10
2
0
11
+1
-1.50
1.433
141.11
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
2
Residue Composition
number
2
A
0
R
0
N
0
D
0
C
0
E
0
Q
2
G
1
H
3
I
3
L
1
K
0
M
3
F
1
P
2
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 1 I: 3 L: 3 K: 1 M: 0 F: 3 P: 1 S: 2 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
18 reviewed residue count
C96H147N21O21 sequence-only estimate (linear, free termini)
1931.35 sequence-only estimate (linear, free termini)
10.10 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
-1.50 sequence-only estimate (linear, free termini)
1.433 sequence-only estimate (linear, free termini)
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
20 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against S. aureus (MIC 20 uM) and C. albicans ( MIC 64 uM), and poorly active against E. coli (MIC 150 uM). It caused 2
Evidence 2 Activity

Activity

MIC
Antibacterial
150 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

ive against S. aureus (MIC 20 uM) and C. albicans ( MIC 64 uM), and poorly active against E. coli (MIC 150 uM). It caused 28% hemolysis at 100 uM (but 65% at 120 uM) and no hemolysis until 40 uM. AamA
Evidence 3 Activity

Activity

MIC
Antifungal
20 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against S. aureus (MIC 20 uM) and C. albicans ( MIC 64 uM), and poorly active against E. coli (MIC 150 uM). It caused 2
Evidence 4 Activity

Activity

MIC
Antifungal
150 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ive against S. aureus (MIC 20 uM) and C. albicans ( MIC 64 uM), and poorly active against E. coli (MIC 150 uM). It caused 28% hemolysis at 100 uM (but 65% at 120 uM) and no hemolysis until 40 uM. AamA
Evidence 5 Activity

Activity

MIC
Antiviral
20 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
Active against S. aureus (MIC 20 uM) and C. albicans ( MIC 64 uM), and poorly active against E. coli (MIC 150 uM). It caused 2
Evidence 6 Activity

Activity

MIC
Antiviral
150 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

ive against S. aureus (MIC 20 uM) and C. albicans ( MIC 64 uM), and poorly active against E. coli (MIC 150 uM). It caused 28% hemolysis at 100 uM (but 65% at 120 uM) and no hemolysis until 40 uM. AamA
Evidence 7 Activity

Activity

10% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
QSAR Reveals Decreased Lipophilicity of Polar Residues Determines the Selectivity of Antimicrobial Peptide Activity. | ACS Omega | 2024
Evidence 8 Activity

Activity

50% Cell death
Toxicity
270.2 µg/mL
Cytotoxic
50% Cell death | 270.2 | µg/mL | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
QSAR Reveals Decreased Lipophilicity of Polar Residues Determines the Selectivity of Antimicrobial Peptide Activity. | ACS Omega | 2024
Evidence 9 Activity

Activity

44.3±20.2% Cell death
Toxicity
256 µg/mL
Cytotoxic
44.3±20.2% Cell death | 256 | µg/mL | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
QSAR Reveals Decreased Lipophilicity of Polar Residues Determines the Selectivity of Antimicrobial Peptide Activity. | ACS Omega | 2024
Evidence 10 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human microvascular endothelial cells HMEC-1

Target

Human microvascular endothelial cells HMEC-1

Source & Reference

NA
DBAASP
Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. | Peptides | 2012
Evidence 11 Activity

Activity

100% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
100% Hemolysis | 100 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. | Peptides | 2012
Evidence 12 Activity

Activity

44% Hemolysis
Toxicity
80 µM
Hemolytic Cytotoxic
44% Hemolysis | 80 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. | Peptides | 2012
Evidence 13 Activity

Activity

13% Hemolysis
Toxicity
60 µM
Hemolytic Cytotoxic
13% Hemolysis | 60 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. | Peptides | 2012
Evidence 14 Activity

Activity

8% Hemolysis
Toxicity
40 µM
Hemolytic Cytotoxic
8% Hemolysis | 40 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. | Peptides | 2012
Evidence 15 Activity

Activity

0% Hemolysis
Toxicity
20 µM
Hemolytic Cytotoxic
0% Hemolysis | 20 | µM | target cell: Horse erythrocytes

Target

Horse erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog. | Peptides | 2012
Evidence 16 Hemolysis

Source & Reference

APD_complete APD_hemolytic PD_Hemolysis
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.